| Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells YF Tian, H Ahn, RS Schneider, SN Yang, L Roman-Gonzalez, AM Melnick, ... Biomaterials 73, 110-119, 2015 | 79 | 2015 |
| Self‐assembled, ellipsoidal polymeric nanoparticles for intracellular delivery of therapeutics P Desai, A Venkataramanan, R Schneider, MK Jaiswal, JK Carrow, ... Journal of Biomedical Materials Research Part A 106 (7), 2048-2058, 2018 | 25 | 2018 |
| Microfluidics generation of chitosan microgels containing glycerylphytate crosslinker for in situ human mesenchymal stem cells encapsulation A Mora-Boza, LMM Castro, RS Schneider, WM Han, AJ García, ... Materials Science and Engineering: C 120, 111716, 2021 | 20 | 2021 |
| High‐throughput on‐chip human mesenchymal stromal cell potency prediction RS Schneider, AC Vela, EK Williams, KE Martin, WA Lam, AJ García Advanced Healthcare Materials 11 (2101995), 2022 | 7 | 2022 |
| Host type 2 immune response to xenogeneic serum components impairs biomaterial-directed osteo-regenerative therapies KE Martin, PP Kalelkar, MM Coronel, HS Theriault, RS Schneider, ... Biomaterials 286, 121601, 2022 | 6 | 2022 |
| Enabling mesenchymal stromal cell immunomodulatory analysis using scalable platforms EK Williams, JR García, RG Mannino, RS Schneider, WA Lam, AJ García Integrative Biology 11 (4), 154-162, 2019 | 6 | 2019 |
| SL-801, a novel, reversible inhibitor of Exportin-1 (XPO1)/Chromosome Region Maintenance-1 (CRM1) with broad and potent anti-cancer activity J Chen, CL Brooks, P McDonald, JD Schwartz, RS Schneider, ... Blood 126 (23), 4433, 2015 | 2 | 2015 |
| Mesenchymal Stem Cell Modulation of the Synthetic Biomaterial Immune Microenvironment KE Martin, RS Schneider, AJ García | | 2022 |
| On-demand Immunomodulation Centers for Reducing Inflammation in Osteoarthritis YF Tian, R Schneider, D Holyoak, MCH van der Meulen, A Singh | | |
Andres J. GarciaGeorgia Institute of TechnologyVerified email at me.gatech.edu
